{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:54:06Z","timestamp":1793120046297,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08461-y","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:50:45Z","timestamp":1781772645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Transcriptional and functional profiling reveals unique activation of Adapter CAR T cells in acute myeloid leukemia"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9652-7343","authenticated-orcid":false,"given":"Nele","family":"Knelangen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika","family":"Bader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Maniaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Engels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Gattinoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Mittelstaet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"8461_CR1","doi-asserted-by":"publisher","unstructured":"Brentjens RJ, Davila ML, Riviere I, Park J, Wang X, Cowell LG, et al. CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Sci Transl Med. 2013, Mar, 20;5(177):177ra38. https:\/\/doi.org\/10.1126\/scitranslmed.3005930 PubMed PMID: 23515080; PubMed Central PMCID: PMC3742551.","DOI":"10.1126\/scitranslmed.3005930"},{"issue":"16","key":"8461_CR2","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","volume":"371","author":"SL Maude","year":"2014","unstructured":"Maude SL, Frey N, Shaw PA, Aplenc R, Barrett DM, Bunin NJ, et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med. 2014, Oct, 16;371(16):1507\u201317. https:\/\/doi.org\/10.1056\/NEJMoa1407222 PubMed PMID: 25317870; PubMed Central PMCID: PMC4267531.","journal-title":"N Engl J Med"},{"key":"8461_CR3","doi-asserted-by":"publisher","unstructured":"Porter DL, Hwang WT, Frey NV, Lacey SF, Shaw PA, Loren AW, et al. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia. Sci Transl Med. 2015, Sep, 2;7(303):303ra139. https:\/\/doi.org\/10.1126\/scitranslmed.aac5415 PubMed PMID: 26333935; PubMed Central PMCID: PMC5909068.","DOI":"10.1126\/scitranslmed.aac5415"},{"issue":"6","key":"8461_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41571-023-00754-1","volume":"20","author":"KM Cappell","year":"2023","unstructured":"Cappell KM, Kochenderfer JN. Long-term outcomes following CAR T cell therapy: what we know so far. Nat Rev Clin Oncol. 2023, Jun;20(6):359\u201371. https:\/\/doi.org\/10.1038\/s41571-023-00754-1 PubMed PMID: 37055515; PubMed Central PMCID: PMC10100620.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"8461_CR5","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","volume":"124","author":"DW Lee","year":"2014","unstructured":"Lee DW, Gardner R, Porter DL, Louis CU, Ahmed N, Jensen M, et al. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014, Jul, 10;124(2):188\u201395. https:\/\/doi.org\/10.1182\/blood-2014-05-552729 PubMed PMID: 24876563; PubMed Central PMCID: PMC4093680.","journal-title":"Blood"},{"key":"8461_CR6","doi-asserted-by":"publisher","first-page":"577027","DOI":"10.3389\/fimmu.2020.577027","volume":"11","author":"J Gust","year":"2020","unstructured":"Gust J, Ponce R, Liles WC, Garden GA, Turtle CJ. Cytokines in CAR T cell\u2013associated neurotoxicity. Front Immunol. 2020;11:577027. https:\/\/doi.org\/10.3389\/fimmu.2020.577027 PubMed PMID: 33391257; PubMed Central PMCID: PMC7772425.","journal-title":"Front Immunol"},{"issue":"5","key":"8461_CR7","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1182\/blood-2011-02-337360","volume":"118","author":"X Wang","year":"2011","unstructured":"Wang X, Chang WC, Wong CW, Colcher D, Sherman M, Ostberg JR, et al. A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells. Blood. 2011, Aug, 4;118(5):1255\u201363. https:\/\/doi.org\/10.1182\/blood-2011-02-337360 PubMed PMID: 21653320; PubMed Central PMCID: PMC3152493.","journal-title":"Blood"},{"key":"8461_CR8","doi-asserted-by":"publisher","first-page":"1026474","DOI":"10.3389\/fmmed.2022.1026474","volume":"2","author":"TB Shabaneh","year":"2022","unstructured":"Shabaneh TB, Moffett HF, Stull SM, Derezes T, Tait LJ, Park S, et al. Safety switch optimization enhances antibody-mediated elimination of CAR T cells. Front Mol Med. 2022;2:1026474. https:\/\/doi.org\/10.3389\/fmmed.2022.1026474 PubMed PMID: 39086975; PubMed Central PMCID: PMC11285702.","journal-title":"Front Mol Med"},{"issue":"18","key":"8461_CR9","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1056\/NEJMoa1106152","volume":"365","author":"A Di Stasi","year":"2011","unstructured":"Di Stasi A, Tey SK, Dotti G, Fujita Y, Kennedy-Nasser A, Martinez C, et al. Inducible apoptosis as a safety switch for adoptive cell therapy. N Engl J Med. 2011, Nov, 3;365(18):1673\u201383. https:\/\/doi.org\/10.1056\/NEJMoa1106152 PubMed PMID: 22047558; PubMed Central PMCID: PMC3236370.","journal-title":"N Engl J Med"},{"issue":"11","key":"8461_CR10","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1182\/blood-2004-11-4564","volume":"105","author":"KC Straathof","year":"2005","unstructured":"Straathof KC, Pul\u00e8 MA, Yotnda P, Dotti G, Vanin EF, Brenner MK, et al. An inducible caspase 9 safety switch for T-cell therapy. Blood. 2005, Jun, 1;105(11):4247\u201354. https:\/\/doi.org\/10.1182\/blood-2004-11-4564 PubMed PMID: 15728125; PubMed Central PMCID: PMC1895037.","journal-title":"Blood"},{"key":"8461_CR11","doi-asserted-by":"publisher","first-page":"748768","DOI":"10.3389\/fimmu.2021.748768","volume":"12","author":"C Liu","year":"2021","unstructured":"Liu C, Qi T, Milner JJ, Lu Y, Cao Y. Speed and location both matter: antigen stimulus dynamics controls CAR-T cell response. Front Immunol. 2021;12:748768. https:\/\/doi.org\/10.3389\/fimmu.2021.748768 PubMed PMID: 34691062; PubMed Central PMCID: PMC8531752.","journal-title":"Front Immunol"},{"issue":"25","key":"8461_CR12","doi-asserted-by":"publisher","first-page":"6081","DOI":"10.1016\/j.cell.2021.11.016","volume":"184","author":"CR Good","year":"2021","unstructured":"Good CR, Aznar MA, Kuramitsu S, Samareh P, Agarwal S, Donahue G, et al. An NK-like CAR T cell transition in CAR T cell dysfunction. Cell. 2021, Dec, 9;184(25):6081\u2013100.e26. https:\/\/doi.org\/10.1016\/j.cell.2021.11.016 PubMed PMID: 34861191; PubMed Central PMCID: PMC8827167.","journal-title":"Cell"},{"issue":"23","key":"8461_CR13","doi-asserted-by":"publisher","first-page":"6436","DOI":"10.1158\/1078-0432.CCR-12-1449","volume":"18","author":"K Tamada","year":"2012","unstructured":"Tamada K, Geng D, Sakoda Y, Bansal N, Srivastava R, Li Z, et al. Redirecting gene-modified T cells toward various cancer types using tagged antibodies. Clin Cancer Res. 2012, Dec, 1;18(23):6436\u201345. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-1449 PubMed PMID: 23032741.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"8461_CR14","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1158\/0008-5472.CAN-11-3890","volume":"72","author":"K Urbanska","year":"2012","unstructured":"Urbanska K, Lanitis E, Poussin M, Lynn RC, Gavin BP, Kelderman S, et al. A universal strategy for adoptive immunotherapy of cancer through use of a novel T-cell antigen receptor. Cancer Res. 2012, Apr, 1;72(7):1844\u201352. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3890 PubMed PMID: 22315351; PubMed Central PMCID: PMC3319867.","journal-title":"Cancer Res"},{"issue":"1","key":"8461_CR15","doi-asserted-by":"publisher","first-page":"2003532","DOI":"10.1080\/2162402X.2021.2003532","volume":"10","author":"CM Seitz","year":"2021","unstructured":"Seitz CM, Mittelstaet J, Atar D, Hau J, Reiter S, Illi C, et al. Novel adapter CAR-T cell technology for precisely controllable multiplex cancer targeting. Oncoimmunology. 2021;10(1):2003532. PubMed PMID: 35686214; PubMed Central PMCID: PMC9172918. https:\/\/doi.org\/10.1080\/2162402X.2021.2003532. PubMed PMID: 35686214; PubMed Central PMCID: PMC9172918.","journal-title":"Oncoimmunology"},{"key":"8461_CR16","doi-asserted-by":"publisher","unstructured":"Rodgers DT, Mazagova M, Hampton EN, Cao Y, Ramadoss NS, Hardy IR, et al. Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies. Proc Natl Acad Sci USA. 2016, Jan, 26;113(4):E459\u2013468. https:\/\/doi.org\/10.1073\/pnas.1524155113 PubMed PMID: 26759369; PubMed Central PMCID: PMC4743815.","DOI":"10.1073\/pnas.1524155113"},{"issue":"21","key":"8461_CR17","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1182\/blood.V124.21.3494.3494","volume":"124","author":"S Koristka","year":"2014","unstructured":"Koristka S, Cartellieri M, Feldmann A, Arndt C, Loff S, Michalk I, et al. Flexible antigen-specific redirection of human regulatory T cells via a novel universal Chimeric antigen receptor System. Blood. 2014, Dec, 6;124(21):3494\u20133494. https:\/\/doi.org\/10.1182\/blood.V124.21.3494.3494.","journal-title":"Blood"},{"issue":"13","key":"8461_CR18","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/pros.22850","volume":"74","author":"C Arndt","year":"2014","unstructured":"Arndt C, Feldmann A, Koristka S, Cartellieri M, Dimmel M, Ehninger A, et al. Simultaneous targeting of prostate stem cell antigen and prostate-specific membrane antigen improves the killing of prostate cancer cells using a novel modular T cell-retargeting system. Prostate. 2014, Sep;74(13):1335\u201346. PubMed PMID: 25053443. https:\/\/doi.org\/10.1002\/pros.22850 PubMed PMID: 25053443.","journal-title":"The Prostate"},{"issue":"10","key":"8461_CR19","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1038\/s41375-024-02351-2","volume":"38","author":"D Atar","year":"2024","unstructured":"Atar D, Ruoff L, Mast AS, Krost S, Moustafa-Oglou M, Scheuermann S, et al. Rational combinatorial targeting by adapter CAR-T-cells (AdCAR-T) prevents antigen escape in acute myeloid leukemia. Leukemia. 2024, Oct;38(10):2183\u201395. https:\/\/doi.org\/10.1038\/s41375-024-02351-2 PubMed PMID: 39095503; PubMed Central PMCID: PMC11436361.","journal-title":"Leukemia"},{"issue":"10","key":"8461_CR20","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.3390\/biomedicines10102420","volume":"10","author":"D Atar","year":"2022","unstructured":"Atar D, Mast AS, Scheuermann S, Ruoff L, Seitz CM, Schlegel P. Adapter CAR T cell therapy for the treatment of B-Lineage lymphomas. Biomedicines. 2022, Sep, 28;10(10):2420. https:\/\/doi.org\/10.3390\/biomedicines10102420 PubMed PMID: 36289682; PubMed Central PMCID: PMC9599140.","journal-title":"Biomedicines"},{"issue":"7","key":"8461_CR21","doi-asserted-by":"publisher","first-page":"7487","DOI":"10.18632\/oncotarget.23556","volume":"9","author":"D Bachmann","year":"2018","unstructured":"Bachmann D, Aliperta R, Bergmann R, Feldmann A, Koristka S, Arndt C, et al. Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells. Oncotarget. 2018, Jan, 26;9(7):7487\u2013500. https:\/\/doi.org\/10.18632\/oncotarget.23556 PubMed PMID: 29484126; PubMed Central PMCID: PMC5800918.","journal-title":"Oncotarget"},{"issue":"6","key":"8461_CR22","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/s41375-023-01905-0","volume":"37","author":"D Nixdorf","year":"2023","unstructured":"Nixdorf D, Sponheimer M, Berghammer D, Engert F, Bader U, Philipp N, et al. Adapter CAR T cells to counteract T-cell exhaustion and enable flexible targeting in AML. Leukemia. 2023, Jun;37(6):1298\u2013310. https:\/\/doi.org\/10.1038\/s41375-023-01905-0 PubMed PMID: 37106163; PubMed Central PMCID: PMC10244166.","journal-title":"Leukemia"},{"issue":"Supplement 1","key":"8461_CR23","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1182\/blood-2021-151727","volume":"138","author":"L Nikolaenko","year":"2021","unstructured":"Nikolaenko L, Mulroney C, Riedell PA, Flinn IW, Cruz JC, Vaidya R, et al. First in human study of an on\/off Switchable CAR-T cell platform targeting CD19 for B cell malignancies (CLBR001 + SWI019). Blood. 2021, Nov;138(Supplement 1(Supplement 1): 2822\u20132822. https:\/\/doi.org\/10.1182\/blood-2021-151727.","journal-title":"Blood"},{"key":"8461_CR24","doi-asserted-by":"publisher","unstructured":"Albert KM, Pinto NR, Taylor MR, Choe M, Pattabhi S, Rawlings-Rhea S, et al. 233 early experience on ENLIGHTen-01: a phase 1 study of FITC-E2 CAR-T cells with CAR adaptor molecule UB-TT170 for relapsed\/refractory osteosarcoma. J Immunother Cancer. 2024, Nov;1(12(Suppl 2): A267. https:\/\/doi.org\/10.1136\/jitc-2024-SITC2024.0233.","DOI":"10.1136\/jitc-2024-SITC2024.0233"},{"issue":"Supplement 1","key":"8461_CR25","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1182\/blood-2023-177867","volume":"142","author":"M Wermke","year":"2023","unstructured":"Wermke M, Metzelder S, Kraus S, Sala E, Vucinic V, Fiedler W, et al. Updated results from a phase I dose escalation study of the rapidly-Switchable universal CAR-T therapy UniCAR-T-CD123 in Relapsed\/Refractory AML. Blood. 2023, Nov;142(Supplement 1(Supplement 1): 3465\u20133465. https:\/\/doi.org\/10.1182\/blood-2023-177867.","journal-title":"Blood"},{"issue":"17","key":"8461_CR26","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.omto.2020.04.009","volume":"17","author":"S Loff","year":"2020","unstructured":"Loff S, Dietrich J, Meyer JE, Riewaldt J, Spehr J, von Bonin M, et al. Rapidly Switchable universal CAR-T cells for treatment of CD123-positive leukemia. Mol Ther - Oncolytics. 2020, Jun;17(17):408\u201320. https:\/\/doi.org\/10.1016\/j.omto.2020.04.009 PubMed PMID: 32462078; PubMed Central PMCID: PMC7240059.","journal-title":"Mol Ther - Oncolytics"},{"key":"8461_CR27","doi-asserted-by":"publisher","unstructured":"Viaud S, Ma JSY, Hardy IR, Hampton EN, Benish B, Sherwood L, et al. Switchable control over in vivo CAR T expansion, B cell depletion, and induction of memory. Proc Natl Acad Sci USA. 2018, Nov, 13;115(46). https:\/\/doi.org\/10.1073\/pnas.1810060115.","DOI":"10.1073\/pnas.1810060115"},{"issue":"6","key":"8461_CR28","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.cmet.2020.11.007","volume":"32","author":"RJ Arg\u00fcello","year":"2020","unstructured":"Arg\u00fcello RJ, Combes AJ, Char R, Gigan JP, Baaziz AI, Bousiquot E, et al. SCENITH: a flow cytometry-based method to functionally profile energy metabolism with single-cell resolution. Cell Metab. 2020, Dec, 1;32(6):1063\u201375.e7. https:\/\/doi.org\/10.1016\/j.cmet.2020.11.007 PubMed PMID: 33264598; PubMed Central PMCID: PMC8407169.","journal-title":"Cell Metab"},{"issue":"13","key":"8461_CR29","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021, Jun, 24;184(13):3573\u201387.e29. https:\/\/doi.org\/10.1016\/j.cell.2021.04.048 PubMed PMID: 34062119.","journal-title":"Cell"},{"issue":"4","key":"8461_CR30","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis CS, Murrow LM, Gartner ZJ. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 2019, Apr, 24;8(4):329\u201337.e4. https:\/\/doi.org\/10.1016\/j.cels.2019.03.003.","journal-title":"Cell Syst"},{"issue":"12","key":"8461_CR31","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019, Dec;16(12):1289\u201396. https:\/\/doi.org\/10.1038\/s41592-019-0619-0 PubMed PMID: 31740819; PubMed Central PMCID: PMC6884693.","journal-title":"Nat Methods"},{"issue":"4","key":"8461_CR32","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M, et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014, Apr;32(4):381\u201386. https:\/\/doi.org\/10.1038\/nbt.2859 PubMed PMID: 24658644; PubMed Central PMCID: PMC4122333.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"8461_CR33","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics: J Intgr Biol. 2012, May;16(5):284\u201387. https:\/\/doi.org\/10.1089\/omi.2011.0118 PubMed PMID: 22455463; PubMed Central PMCID: PMC3339379.","journal-title":"Omics: J Intgr Biol"},{"issue":"3","key":"8461_CR34","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innov. 2021, Aug, 28;2(3):100141. PubMed PMID: 34557778; PubMed Central PMCID: PMC8454663. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141 PubMed PMID: 34557778; PubMed Central PMCID: PMC8454663.","journal-title":"The Innov"},{"issue":"11","key":"8461_CR35","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1038\/s41596-024-01020-z","volume":"19","author":"S Xu","year":"2024","unstructured":"Xu S, Hu E, Cai Y, Xie Z, Luo X, Zhan L, et al. Using clusterProfiler to characterize multiomics data. Nat Protoc. 2024, Jul, 17;19(11):3292\u2013320. https:\/\/doi.org\/10.1038\/s41596-024-01020-z PubMed PMID: 39019974.","journal-title":"Nat Protoc"},{"key":"8461_CR36","doi-asserted-by":"publisher","first-page":"117034","DOI":"10.1016\/j.taap.2024.117034","volume":"490","author":"M Stoddard","year":"2024","unstructured":"Stoddard M, Yuan L, Cooper J, Carcillo Neumar C, Hibner B, Gardner H, et al. Can we do better with Mylotarg? model-based assessment of opportunities to improve therapeutic index. Toxicol Appl Pharm. 2024, Sep;490:117034. https:\/\/doi.org\/10.1016\/j.taap.2024.117034 PubMed PMID: 39009139.","journal-title":"Toxicol Appl Pharm"},{"issue":"1","key":"8461_CR37","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.gendis.2022.11.022","volume":"11","author":"Z Zuo","year":"2024","unstructured":"Zuo Z, Zhou Z, Chang Y, Liu Y, Shen Y, Li Q, et al. Ribonucleotide reductase M2 (RRM2): regulation, function and targeting strategy in human cancer. Genes & Dis. 2024, Jan;11(1):218\u201333. https:\/\/doi.org\/10.1016\/j.gendis.2022.11.022 PubMed PMID: 37588202; PubMed Central PMCID: PMC10425756.","journal-title":"Genes & Dis"},{"issue":"7","key":"8461_CR38","doi-asserted-by":"publisher","first-page":"111639","DOI":"10.1016\/j.celrep.2022.111639","volume":"41","author":"J Fern\u00e1ndez-Garc\u00eda","year":"2022","unstructured":"Fern\u00e1ndez-Garc\u00eda J, Franco F, Parik S, Altea-Manzano P, Pane AA, Broekaert D, et al. CD8+ T cell metabolic rewiring defined by scRNA-seq identifies a critical role of ASNS expression dynamics in T cell differentiation. Cell Rep. 2022, Nov, 15;41(7):111639. https:\/\/doi.org\/10.1016\/j.celrep.2022.111639 PubMed PMID: 36384124.","journal-title":"Cell Rep"},{"issue":"6","key":"8461_CR39","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/intimm\/dxf028","volume":"14","author":"A Kelso","year":"2002","unstructured":"Kelso A, Costelloe EO, Johnson BJ, Groves P, Buttigieg K, Fitzpatrick DR. The genes for perforin, granzymes A\u2013C and IFN-\u03b3 are differentially expressed in single CD8+ T cells during primary activation. Int Immunol. 2002;14(6):605\u201313. PubMed PMID: 12039912. PubMed PMID: 12039912. https:\/\/doi.org\/10.1093\/intimm\/dxf028. PubMed PMID: 12039912.","journal-title":"Int Immunol"},{"issue":"1","key":"8461_CR40","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s13059-023-03120-7","volume":"24","author":"M Rade","year":"2023","unstructured":"Rade M, B\u00f6hlen S, Neuhaus V, L\u00f6ffler D, Blumert C, Merz M, et al. A time-resolved meta-analysis of consensus gene expression profiles during human T-cell activation. Genome Biol. 2023;24(1):287. PubMed PMID: 38098113; PubMed Central PMCID: PMC10722659. https:\/\/doi.org\/10.1186\/s13059-023-03120-7.","journal-title":"Genome Biol"},{"key":"8461_CR41","doi-asserted-by":"publisher","unstructured":"Cartellieri M, Feldmann A, Koristka S, Arndt C, Loff S, Ehninger A, et al. Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts. Blood Cancer J. 2016, Aug, 12;6(8):e458. https:\/\/doi.org\/10.1038\/bcj.2016.61 PubMed PMID: 27518241; PubMed Central PMCID: PMC5022178.","DOI":"10.1038\/bcj.2016.61"},{"key":"8461_CR42","doi-asserted-by":"publisher","unstructured":"Gemta LF, Siska PJ, Nelson ME, Gao X, Liu X, Locasale JW, et al. Impaired enolase 1 glycolytic activity restrains effector functions of tumor-infiltrating CD8+ T cells. Sci Immunol. 2019, Jan, 25;4(31):eaap9520. https:\/\/doi.org\/10.1126\/sciimmunol.aap9520 PubMed PMID: 30683669; PubMed Central PMCID: PMC6824424.","DOI":"10.1126\/sciimmunol.aap9520"},{"issue":"6","key":"8461_CR43","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.cell.2013.05.016","volume":"153","author":"CH Chang","year":"2013","unstructured":"Chang CH, Curtis JD, Maggi LB, Faubert B, Villarino AV, O\u2019Sullivan D, et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell. 2013, Jun, 6;153(6):1239\u201351. https:\/\/doi.org\/10.1016\/j.cell.2013.05.016 PubMed PMID: 23746840; PubMed Central PMCID: PMC3804311.","journal-title":"Cell"},{"issue":"2","key":"8461_CR44","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.immuni.2012.10.020","volume":"38","author":"LA Sena","year":"2013","unstructured":"Sena LA, Li S, Jairaman A, Prakriya M, Ezponda T, Hildeman DA, et al. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity. 2013, Feb, 21;38(2):225\u201336. https:\/\/doi.org\/10.1016\/j.immuni.2012.10.020 PubMed PMID: 23415911; PubMed Central PMCID: PMC3582741.","journal-title":"Immunity"},{"issue":"4\u20135","key":"8461_CR45","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00210-011-0649-3","volume":"384","author":"M Boissan","year":"2011","unstructured":"Boissan M, Lacombe ML. Learning about the functions of NME\/NM23: lessons from knockout mice to silencing strategies. Naunyn-Schmiedeberg\u2019s Arch Pharmacol. 2011, Oct;384(4\u20135):421\u201331. https:\/\/doi.org\/10.1007\/s00210-011-0649-3.","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"1","key":"8461_CR46","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1038\/s41467-019-12464-3","volume":"10","author":"PA Szabo","year":"2019","unstructured":"Szabo PA, Levitin HM, Miron M, Snyder ME, Senda T, Yuan J, et al. Single-cell transcriptomics of human T cells reveals tissue and activation signatures in health and disease. Nat Commun. 2019, Oct, 17;10(1):4706. https:\/\/doi.org\/10.1038\/s41467-019-12464-3.","journal-title":"Nat Commun"},{"issue":"20","key":"8461_CR47","doi-asserted-by":"publisher","first-page":"10832","DOI":"10.1073\/pnas.170276797","volume":"97","author":"S Sato","year":"2000","unstructured":"Sato S, Fujita N, Tsuruo T. Modulation of Akt kinase activity by binding to Hsp90. Proc Natl Acad Sci USA. 2000, Sep, 26;97(20):10832\u201337. https:\/\/doi.org\/10.1073\/pnas.170276797 PubMed PMID: 10995457; PubMed Central PMCID: PMC27109.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"8461_CR48","doi-asserted-by":"publisher","first-page":"1012509","DOI":"10.1155\/2022\/1012509","volume":"2022","author":"S Zhang","year":"2022","unstructured":"Zhang S, Fan S, Wang Z, Hou W, Liu T, Yoshida S, et al. Capecitabine regulates HSP90AB1 expression and induces apoptosis via Akt\/SMARCC1\/AP-1\/ROS axis in T cells. Oxidative Med Cellular Longevity. 2022;2022(1):1012509. https:\/\/doi.org\/10.1155\/2022\/1012509 PubMed PMID: 35368874; PubMed Central PMCID: PMC8970866.","journal-title":"Oxidative Med Cellular Longevity"},{"issue":"1","key":"8461_CR49","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12864-021-07435-2","volume":"22","author":"Y Huo","year":"2021","unstructured":"Huo Y, Sheng Z, Lu DR, Ellwanger DC, Li CM, Homann O, et al. Blinatumomab-induced T cell activation at single cell transcriptome resolution. BMC Genomics. 2021, Mar, 1;22(1):145. https:\/\/doi.org\/10.1186\/s12864-021-07435-2 PubMed PMID: 33648458; PubMed Central PMCID: PMC7923532.","journal-title":"BMC Genomics"},{"issue":"7","key":"8461_CR50","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.4049\/jimmunol.178.7.4650","volume":"178","author":"AA Hombach","year":"2007","unstructured":"Hombach AA, Schildgen V, Heuser C, Finnern R, Gilham DE, Abken H. T cell activation by Antibody-Like Immunoreceptors: the position of the binding epitope within the target molecule determines the efficiency of activation of redirected T cells. J Immunol. 2007, Apr, 1;178(7):4650\u201357. https:\/\/doi.org\/10.4049\/jimmunol.178.7.4650.","journal-title":"J Immunol"},{"issue":"12","key":"8461_CR51","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1158\/1078-0432.CCR-13-0330","volume":"19","author":"M Hudecek","year":"2013","unstructured":"Hudecek M, Lupo-Stanghellini MT, Kosasih PL, Sommermeyer D, Jensen MC, Rader C, et al. Receptor affinity and extracellular domain modifications affect tumor recognition by ROR1-specific chimeric antigen receptor T cells. Clin Cancer Res. 2013, Jun, 15;19(12):3153\u201364. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-0330 PubMed PMID: 23620405; PubMed Central PMCID: PMC3804130.","journal-title":"Clin Cancer Res"},{"key":"8461_CR52","doi-asserted-by":"publisher","unstructured":"Leithner A, Staufer O, Mitra T, Liberta F, Valvo S, Kutuzov M, et al. Solution structure and synaptic analyses reveal determinants of bispecific T cell engager potency. Proc Natl Acad Sci USA. 2025, Jun, 3;122(22):e2425781122. https:\/\/doi.org\/10.1073\/pnas.2425781122 PubMed PMID: 40445758; PubMed Central PMCID: PMC12146755.","DOI":"10.1073\/pnas.2425781122"},{"key":"8461_CR53","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.imlet.2017.02.006","volume":"184","author":"X Wang","year":"2017","unstructured":"Wang X, Yang L, Huang F, Zhang Q, Liu S, Ma L, et al. Inflammatory cytokines IL-17 and TNF-\u03b1 up-regulate PD-L1 expression in human prostate and colon cancer cells. Immunol Lett. 2017, Apr;184:7\u201314. https:\/\/doi.org\/10.1016\/j.imlet.2017.02.006 PubMed PMID: 28223102; PubMed Central PMCID: PMC5362328.","journal-title":"Immunol Lett"},{"issue":"1","key":"8461_CR54","doi-asserted-by":"publisher","first-page":"12320","DOI":"10.1038\/ncomms12320","volume":"7","author":"E Jacoby","year":"2016","unstructured":"Jacoby E, Nguyen SM, Fountaine TJ, Welp K, Gryder B, Qin H, et al. CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity. Nat Commun. 2016, Jul, 27;7(1):12320. https:\/\/doi.org\/10.1038\/ncomms12320 PubMed PMID: 27460500; PubMed Central PMCID: PMC4974466.","journal-title":"Nat Commun"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08461-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08461-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08461-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T10:59:18Z","timestamp":1782125958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08461-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8461"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08461-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required for the studies on humans in concordance with the local legislation and institutional requirements because Buffy coats were provided by Klinikum Dortmund or German Red Cross Hagen with written informed consent before sample collection and commercially available cell lines were used.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NK, UB, EM, BE are employees of Miltenyi Biotec B.V. & Co. KG. JM has a patent application pending for the AdCAR system presented in this publication. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"794"}}